Silencing NLRP3 or using the antioxidant N-acetyl-L-cysteine (NAC) reduced inflammasome activation and atherosclerosis, indicating that NLRP3 activation is a key mediator of HHcy-induced vascular inflammation [124]. Here, NLRP3 is linked to atherosclerosis.